Nchi: Uholanzi
Lugha: Kiholanzi
Chanzo: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
LIDOCAÏNE
Grunenthal B.V. De Corridor 21K 3621 ZA BREUKELEN
N01BB02
LIDOCAINE
Pleister
ALUMINIUMGLYCINAAT 0-WATER ; CARMELLOSE NATRIUM (E 466) ; DINATRIUMEDETAAT 2-WATER ; GELATINE (E 441) ; GLYCEROL (E 422) ; KAOLIEN ; METHYLPARAHYDROXYBENZOAAT (E 218) ; POLYACRYLAAT NATRIUM ; POLYACRYLZUUR ; POLYETHYLEENTEREPHTHALAAT ; POLYVINYLALCOHOL (E1203) ; PROPYLEENGLYCOL (E 1520) ; PROPYLPARAHYDROXYBENZOAAT (E 216) ; SORBITOL, VLOEIBAAR, KRISTALLISEERBAAR (E 420) ; UREUM (E 927B) ; WATER, GEZUIVERD ; WIJNSTEENZUUR, (L (+) Vorm) (E 334),
Cutaan gebruik
Lidocaine
Hulpstoffen: ALUMINIUMGLYCINAAT 0-WATER; CARMELLOSE NATRIUM (E 466); DINATRIUMEDETAAT 2-WATER; GELATINE (E 441); GLYCEROL (E 422); KAOLIEN; METHYLPARAHYDROXYBENZOAAT (E 218); POLYACRYLAAT NATRIUM; POLYACRYLZUUR; POLYETHYLEENTEREPHTHALAAT; POLYVINYLALCOHOL (E1203); PROPYLEENGLYCOL (E 1520); PROPYLPARAHYDROXYBENZOAAT (E 216); SORBITOL, VLOEIBAAR, KRISTALLISEERBAAR (E 420); UREUM (E 927B); WATER, GEZUIVERD; WIJNSTEENZUUR, (L (+) Vorm) (E 334);
2017-09-04
Lonqtiv 700 mg medicated plaster Page 1 of 6 1 PACKAGE LEAFLET: INFORMATION FOR THE USER LONQTIV 700 MG, PLEISTER Lidocaine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Lonqtiv is and what it is used for 2. What you need to know before you use Lonqtiv 3. How to use Lonqtiv 4. Possible side effects 5. How to store Lonqtiv 6. Contents of the pack and other information 1. WHAT LONQTIV IS AND WHAT IT IS USED FOR Lonqtiv contains lidocaine, a local analgesic, which works by reducing the pain in your skin. You have been given Lonqtiv to treat a painful skin condition called post-herpetic neuralgia. This is generally characterised by localised symptoms such as burning, shooting or stabbing pain. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE LONQTIV DO NOT USE LONQTIV - if you are allergic to lidocaine or any of the other ingredients of this medicine (listed in section 6). - if you have had an allergic reaction to other products which are similar to lidocaine, such as bupivacaine, etidocaine, mepivacaine or prilocaine. - on injured skin or open wounds WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before using Lonqtiv. If you have severe liver disease, or severe heart problems, or severe kidney problems, you should talk to your doctor before using Lonqtiv. Lonqtiv should only be used on the areas of skin after the shingles has healed. It should not be used on or near the eyes or mouth. Lidocaine is broken down in your liver to several compounds. One of these compounds is 2,6 xylidine which has b Soma hati kamili
Lonqtiv 700 mg medicated plaster Page 1 of 8 1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Lonqtiv 700 mg, pleister 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 10 cm x 14 cm plaster contains 700 mg lidocaine (5%w/w) Excipients with known effect: Methyl parahydroxybenzoate 14 mg Propyl parahydroxybenzoate 7 mg Propylene glycol 700 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Medicated plaster White hydrogel plaster containing adhesive material, which is applied to a non-woven polyethylene terephthalate backing embossed with “Lidocaine 5%” and covered with a polyethylene terephthalate film release liner. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Lonqtiv is indicated for the symptomatic relief of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia, PHN) in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _ADULTS AND ELDERLY PATIENTS _ The painful area should be covered with the plaster once daily for up to 12 hours within a 24 hours period. Only the number of plasters that are needed for an effective treatment should be used. When needed, the plasters may be cut into smaller sizes with scissors prior to removal of the release liner. In total, not more than three plasters should be used at the same time. The plaster must be applied to intact, dry, non-irritated skin (after healing of the shingles). Each plaster must be worn no longer than 12 hours. The subsequent plaster-free interval must be at least 12 hours. The plaster can be applied during the day or during the night. The plaster must be applied to the skin immediately after removal from the sachet and following removal of the release liner from the gel surface. Hairs in the affected area must be cut off with a pair of scissors (not shaved). Treatment outcome should be re-evaluated after 2-4 weeks. If there has been no response to Lonqtiv after this period (during the wearing time and/or during the plaster-free interval), treatment must be discontinu Soma hati kamili